Antiviral effect of a commercially phytotherapeutic compound against feline immunodeficiency virus

Nat Prod Res. 2022 Aug;36(16):4159-4164. doi: 10.1080/14786419.2021.1960329. Epub 2021 Sep 29.

Abstract

The feline immunodeficiency virus (FIV) is a widespread lentivirus of felids. Due to its worldwide diffusion and the lack of an effective preventive and therapeutic protocol, it has a high impact on the cats' health. Several therapeutical protocols have been proposed, among those, phytotherapeutic compounds have been tested with the purpose to find a possible natural treatment. The most studied active compounds are derived from Ganoderma lucidum, Cordyceps sinensis, and Trametes versicolor. The present study aims to investigate in vitro antiviral effects of a commercially available compound HELP-TH1 (Camon, S.p.A., Italy) against FIV. The antiviral effect of HELP-TH1 was evaluated by quantifying and comparing the viral load of control groups, infected and not-treated cells, vs both experimental groups, infected and treated cells. Our data indicate that HELP-TH1 reduce the viral load in the experimental conditions demonstrating its antiviral effect.

Keywords: Feline immunodeficiency virus; antiviral activity; phytotherapy.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Cats
  • Feline Acquired Immunodeficiency Syndrome* / drug therapy
  • Immunodeficiency Virus, Feline*
  • Italy
  • Trametes

Substances

  • Antiviral Agents